AzTrials
AzTrials

Psychological DistressNCT04368312

Psychological Impairment Due to Covid-19

An observational study of Psychological Distress and Quality of Life, run by University Hospital, Essen at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hospital staff and emergency personnel are expected to suffer impaired psychological outcomes during a pandemic in terms of Quality of Life, anxiety, depression or other outcomes. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Psychological Distress, Quality of Life
How many people
100 participants
Where
1 siteGermany
Study dates
6 May 2020to 30 Dec 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Inclusion of all persons which can be attributed to hospital stuff, those include doctors and nurses (male/female)

Who may be able to join

  • Hospital staff (doctors and nurses)

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University Hospital Essen

    Essen, North Rhine-Westphalia, 45147

Other trials in Germany

About this study

Official title: Psychological Impairment Due to Covid-19 in Hospital Staff

Hospital staff and emergency personnel are expected to suffer impaired psychological outcomes during a pandemic in terms of Quality of Life, anxiety, depression or other outcomes. The Covid-19 pandemic is a threat for both somatic and psychological health, therefore the impact of the impairment of this event on psychological parameters has to be assessed.

Read the detailed description

Hospital staff and emergency personell are confronted with severe and life-threatening situations, therefore this group is considered to be at risk for impaired psychological health. A pandemic such as the Covid-19 endemic is suggested to severely impair the psychological state of this profession, amongst others Quality of life, anxiety, depression and other parameters. Therefore, it is crucial to assess the impact of impairment due to this global threat on the psychological health of health care providers. We therefore designed this study to evaluate baseline psychological characteristics and to re-assess those values in an interval of 60 days.

Being tested
No intervention
Keywords
quality of life, psychological distress

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

    No intervention, just of questionnaire including validated tests

Study groups in NCT04368312
Study groupRoleWhat they receive
Health care providers/hospital staffThe targeted group are doctors and nurses (hospital stuff) of a large university hospital directly confronted with patients with Cov-19
Receives: Other: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PCL5 Questionnaire

    Validated 20-items questionnaire for PTSD

    Measured: 14 days

  2. BSI - Brief symptom inventory

    The Brief Symptom Inventory (BSI) is a 53-item screener for mental health problems with 9 subscales.

    Measured: 14 days

  3. PHQD

    Instrument for psychological diagnostics, able to test the severity of mental disorders and the success of their treatment

    Measured: 14 days

  4. WHO - QoL BREF

    Qol Questionnaire, assessed QoL with respect to the individual's perceptions in the context of culture and value systems.

    Measured: 14 days

  5. STAXI

    The State-Trait Anger Expression Inventory is used to measure the expressions \& control of anger

    Measured: 14 days

  6. AUDIT questionnaire

    The AUDIT questionnaire is designed to help in the self assessment of alcohol consumption

    Measured: 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2020
  2. Study start6 May 2020
  3. Primary completion30 Sep 2020
  4. Study completion30 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04368312
Sponsor's protocol ID
TEMP553914-BO
Status last verified
May 2021
First submitted
9 Apr 2020
Last updated
6 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wesemann U, Hadjamu N, Wakili R, Willmund G, Vogel J, Rassaf T, Siebermair J. Gender Differences in Anger Among Hospital Medical Staff Exposed to Patients with COVID-19. Health Equity. 2021 Apr 19;5(1):181-184. doi: 10.1089/heq.2020.0119. eCollection 2021.

    PubMed 33937603

Questions about this trial

What is this clinical trial studying?

An observational study of Psychological Distress and Quality of Life, run by University Hospital, Essen at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PCL5 Questionnaire (time frame: 14 days). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04368312, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in